Matt Holt

We have a US-based

healthcare system and a technology infrastructure that's based on the claim or the transaction, fundamentally putting the patient at the center of the IT system is a further enablement tool to evolve the system to a more outcomes-based and healthier system at the system level.

Duplication of service.

performing unnecessary service is a part of what's driving the costs to inflated levels.

Ultimately, if we can have an underlying patient ID system, which is ensuring precision-based and accurate performance and delivery of service and products, will ultimately create efficiency in the system, but also drive better outcomes.

I would say this, there is a counterintuitive element that I believe should be a point of focus for the industry that I think will ultimately unlock a lot more value for the patient, which is to expand privacy protections to all healthcare data uses.

That is something that has been really at odds with a lot of the industry participants who have been looking for data liquidity.

But ultimately, the expansion of privacy protections is critical to building a system that the patients trust.

So that's fundamentally, I think, an objective that private market participants as well as the government should focus on to enable the right data liquidity.

Yes, exactly.

Fundamentally, the value proposition of data controls is fundamental to then unleashing the AI technologies to be able to have access to the right information in a way that society and the patient population can ultimately have trust in, which is fundamental for the system to work.

So that concept of data controls, certification, compliance with consent, with stakeholder participation is fundamental.

Absolutely.

We live in a world that's increasingly dangerous with respect to cybersecurity, hacks, patient information, healthcare information is the most sensitive in the world.

But ultimately, it's another reason that

Data controls and systems are fundamental to creating a marketplace for the use of this data, which will, again, unlock the power of AI in this market.

And what I always point out to people is, just to highlight the complexity of the market, if you go out into the market and you say,

who owns the patient's data?

The provider who provides the care will say that they own the data.

Health insurance company or the employer or the funding source that's paying for and reimbursing the care will say they own the data.